2m 2m 2m 2m 2m 2m 2m
MINK THERAP (INKT)
NASDAQ
$11.17+$0.01 (+0.13%)
Price as of Jul 14, 2026 8:32 AM EDT- $55.5MMarket Cap
- -72.54%1-Year Change
- BiotechnologyIndustry
MINK THERAP (INKT)
$11.17+$0.01 (+0.13%)
INKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.15 | ||
Change | +$0.10 (+0.90%) | ||
Open | $10.72 | ||
High | $11.49 | ||
Low | $10.72 | ||
Previous Close | $11.05 | ||
Volume | 10,556 | ||
30-Day Average Volume | 17,783 | ||
1-Week Change | -3.55% | ||
1-Month Change | -7.24% | ||
1-Year Change | -72.54% | ||
3-Year Change | -40.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.0M | ||
Total Assets | $10.4M | ||
Market Cap | $55.5M | ||
Enterprise Value | $51.0M | ||
Period: QTR TTM FY | |||
Revenue | $80,834.00 | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $2.7M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 631 | ||
P/B | -4 | ||
P/E | -20 | ||
PEG | 8 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/28/2025 | ||
Earnings & Revenue